SkinHealth Systems Inc. (SKIN) stock
SKINNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30316% above fair value
$13.88−1.18 (-7.81%)
Close on Nov 17, 2026Market cap $1.81BP/E –Yield –
SkinHealth Systems gross margin
Gross margin is gross profit as a percentage of revenue.
SkinHealth Systems's gross margin for the twelve months ending Jun 30, 2026 was 66.4%. For fiscal 2025 it was 65.3%, against 54.5% the year before. The highest annual figure on record is 68.6% in fiscal 2021.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 65.3% | +10.8 |
| FY2024 | Dec 31, 2024 | 54.5% | +15.6 |
| FY2023 | Dec 31, 2023 | 39.0% | −29.0 |
| FY2022 | Dec 31, 2022 | 68.0% | −0.7 |
| FY2021 | Dec 31, 2021 | 68.6% | +12.2 |
| FY2020 | Dec 31, 2020 | 56.4% | −7.5 |
| FY2019 | Dec 31, 2019 | 63.9% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 68.4% | +5.6 |
| Q1 FY2026 | Mar 31, 2026 | 68.5% | −1.4 |
| Q4 FY2025 | Dec 31, 2025 | 64.4% | +1.7 |
| Q3 FY2025 | Sep 30, 2025 | 64.6% | +13.0 |
| Q2 FY2025 | Jun 30, 2025 | 62.8% | +17.6 |
| Q1 FY2025 | Mar 31, 2025 | 69.8% | +10.4 |
| Q4 FY2024 | Dec 31, 2024 | 62.7% | +15.5 |
| Q3 FY2024 | Sep 30, 2024 | 51.6% | +64.5 |
| Q2 FY2024 | Jun 30, 2024 | 45.2% | −12.6 |
| Q1 FY2024 | Mar 31, 2024 | 59.4% | −3.3 |
| Q4 FY2023 | Dec 31, 2023 | 47.2% | −20.6 |
| Q3 FY2023 | Sep 30, 2023 | -12.9% | −82.0 |
| Q2 FY2023 | Jun 30, 2023 | 57.8% | −9.9 |
| Q1 FY2023 | Mar 31, 2023 | 62.7% | −4.8 |
| Q4 FY2022 | Dec 31, 2022 | 67.8% | −0.9 |
| Q3 FY2022 | Sep 30, 2022 | 69.1% | +1.5 |
| Q2 FY2022 | Jun 30, 2022 | 67.6% | −3.4 |
| Q1 FY2022 | Mar 31, 2022 | 67.5% | +0.7 |
| Q4 FY2021 | Dec 31, 2021 | 68.7% | +7.8 |
| Q3 FY2021 | Sep 30, 2021 | 67.6% | +7.0 |
| Q2 FY2021 | Jun 30, 2021 | 71.0% | +40.8 |
| Q1 FY2021 | Mar 31, 2021 | 66.8% | – |
| Q4 FY2020 | Dec 31, 2020 | 60.8% | – |
| Q3 FY2020 | Sep 30, 2020 | 60.6% | – |
| Q2 FY2020 | Jun 30, 2020 | 30.3% | – |
See a number that looks wrong?